PRMDPromomed
+0.4% today · +11.6% over a year
5/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 60% of the instruments we score
Trend, Stability: among the best of its peers; priced higher than most peers. Dividend yield 1.90%.
Promomed (PRMD) belongs to the Health care sector and is listed on Moscow Exchange; country: Russia. Over the past 12 months the price changed by +11.6%, with an annualised volatility of 24% and a largest fall of 24%.
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: all companies in Russia (n = 265)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Volatility (1 y)supports the score · better than 96% of peers
- Max drawdown (3 y)supports the score · better than 95% of peers
- Revenue growth (1 y)supports the score · better than 98% of peers
Red flags and notes
- Caution. Dividends exceed earnings or free cash flow. More in the glossary → Dividends exceed earnings or free cash flow.
- Caution. Russian issuer or venue: EU/US sanctions, custody and dividend-transfer restrictions apply; check what your broker allows. More in the glossary → Russian issuer or venue: EU/US sanctions, custody and dividend-transfer restrictions apply; check what your broker allows.
Sanctions, capital controls and custody chains affect who can buy, hold and receive dividends from this security.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Dividends
- Dividend yield
- 1.90%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +0.4%
- 1 month
- +5.8%
- 1 year
- +11.6%
- Volatility, 1 yr
- 23.8%
- Max drawdown, 1 yr
- −24.3%
- Beta
- 0.79
Returns are price changes from end-of-day prices, without dividends.
Similar companies
Same sector, closest in price swings over the past year.
| HSICHenry Schein | 10/10 | 0.0% | 27.6% |
|---|---|---|---|
| DGXQuest Diagnostics | 10/10 | 1.4% | 40.5% |
| MDMGMother and Child (MD Medical Group) | 7/10 | 6.6% | 0.8% |
| RPRXRoyalty Pharma plc | 6/10 | 1.4% | 81.5% |
| LHLabcorp Holdings | 8/10 | 0.8% | 38.7% |
| NOVNNovartis AG | 10/10 | 2.8% | 36.2% |
| RORoche Holding AG (bearer shares) | —/10 | 2.7% | 51.5% |
| SANSanofi SA | 9/10 | 5.1% | −1.6% |
News and filings
No recent news or filings in our sources.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 9 entries
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| Rating change | 5/10 | 4 · 3 | — | Available with Invest Pro | |
| Rating change | 5/10 | 5 · 3 | — | Available with Invest Pro | |
| Rating change | 5/10 | 4 · 3 | — | Available with Invest Pro | |
| Rating change | 5/10 | 5 · 3 | — | Available with Invest Pro | |
| Rating change | 5/10 | 4 · 3 | — | Available with Invest Pro | |
| Rating change | 4 → 5/10 | 5 · 3 | — | Available with Invest Pro | |
| Rating change | 5 → 4/10 | 4 · 3 | — | Available with Invest Pro | |
| Rating change | 4 → 5/10 | 4 · 3 | — | Available with Invest Pro | |
| First rating | 4/10 | 4 · 3 | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.